These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 24589724)

  • 61. 5-Hydroxyhexanoic Acid Predicts Early Renal Functional Decline in Type 2 Diabetes Patients with Microalbuminuria.
    Tang X; You J; Liu D; Xia M; He L; Liu H
    Kidney Blood Press Res; 2019; 44(2):245-263. PubMed ID: 31071709
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Differential proteome profiling using iTRAQ in microalbuminuric and normoalbuminuric type 2 diabetic patients.
    Jin J; Ku YH; Kim Y; Kim Y; Kim K; Lee JY; Cho YM; Lee HK; Park KS; Kim Y
    Exp Diabetes Res; 2012; 2012():168602. PubMed ID: 22536212
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Novel Model Predicts Diabetic Nephropathy in Type 2 Diabetes.
    Jiang S; Fang J; Yu T; Liu L; Zou G; Gao H; Zhuo L; Li W
    Am J Nephrol; 2020; 51(2):130-138. PubMed ID: 31865340
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Urinary peptidome and diabetic retinopathy in the DIRECT-Protect 1 and 2 trials.
    Rotbain Curovic V; Magalhães P; He T; Hansen TW; Mischak H; Rossing P;
    Diabet Med; 2021 Sep; 38(9):e14634. PubMed ID: 34228837
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Levels and Clinical Significances of Glypican-5 in Urine of Type 2 Diabetic Nephropathy Cases.
    Li R; Zhang L; Zhang S; Yang H; Yao B; Dong W; Zhang B; Chen Y; Liu S; Zhao X; Zhang Q; Shi W; Liang X
    Iran J Kidney Dis; 2019 May; 13(3):173-181. PubMed ID: 31209190
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Diabetic nephropathy: traditional to proteomic markers.
    Moresco RN; Sangoi MB; De Carvalho JA; Tatsch E; Bochi GV
    Clin Chim Acta; 2013 Jun; 421():17-30. PubMed ID: 23485645
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Risk prediction of diabetic nephropathy using machine learning techniques: A pilot study with secondary data.
    Maniruzzaman M; Islam MM; Rahman MJ; Hasan MAM; Shin J
    Diabetes Metab Syndr; 2021; 15(5):102263. PubMed ID: 34482122
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparison of intrarenal renin-angiotensin system activity in diabetic versus non-diabetic patients with overt proteinuria.
    Park JH; Jang HR; Lee JH; Lee JE; Huh W; Lee KB; Kwon YJ; Do JY; Kim HY; Kim YG
    Nephrology (Carlton); 2015 Apr; 20(4):279-85. PubMed ID: 25522682
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Urinary mitochondrial DNA: A potential early biomarker of diabetic nephropathy.
    Cao H; Wu J; Luo J; Chen X; Yang J; Fang L
    Diabetes Metab Res Rev; 2019 May; 35(4):e3131. PubMed ID: 30677222
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Biomarkers for Detecting Kidney Dysfunction in Type-2 Diabetics and Diabetic Nephropathy Subjects: A Case-Control Study to Identify Potential Biomarkers of DN to Stratify Risk of Progression in T2D Patients.
    Harkin C; Cobice D; Brockbank S; Bolton S; Johnston F; Strzelecka A; Watt J; Kurth MJ; Lamont JV; Fitzgerald P; Moore T; Ruddock MW
    Front Endocrinol (Lausanne); 2022; 13():887237. PubMed ID: 35846341
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Novel Urinary Biomarkers For Improved Prediction Of Progressive Egfr Loss In Early Chronic Kidney Disease Stages And In High Risk Individuals Without Chronic Kidney Disease.
    Rodríguez-Ortiz ME; Pontillo C; Rodríguez M; Zürbig P; Mischak H; Ortiz A
    Sci Rep; 2018 Oct; 8(1):15940. PubMed ID: 30374033
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Urinary Excretion of Kidney Aquaporins as Possible Diagnostic Biomarker of Diabetic Nephropathy.
    Rossi L; Nicoletti MC; Carmosino M; Mastrofrancesco L; Di Franco A; Indrio F; Lella R; Laviola L; Giorgino F; Svelto M; Gesualdo L; Procino G
    J Diabetes Res; 2017; 2017():4360357. PubMed ID: 28246612
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Urinary biomarkers of tubular injury to predict renal progression and end stage renal disease in type 2 diabetes mellitus with advanced nephropathy: A prospective cohort study.
    Satirapoj B; Pooluea P; Nata N; Supasyndh O
    J Diabetes Complications; 2019 Sep; 33(9):675-681. PubMed ID: 31227289
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Urine IgM-excretion as a prognostic marker for progression of type 2 diabetic nephropathy.
    Tofik R; Torffvit O; Rippe B; Bakoush O
    Diabetes Res Clin Pract; 2012 Jan; 95(1):139-44. PubMed ID: 22078636
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Zinc alpha 2 glycoprotein as an early biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus.
    Elsheikh M; Elhefnawy KA; Emad G; Ismail M; Borai M
    J Bras Nefrol; 2019; 41(4):509-517. PubMed ID: 30897192
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Urinary proteins detected using modern proteomics intervene in early type 2 diabetic kidney disease - a pilot study.
    Golea-Secara A; Munteanu C; Sarbu M; Cretu OM; Velciov S; Vlad A; Bob F; Gadalean F; Gluhovschi C; Milas O; Simulescu A; Mogos-Stefan M; Patruica M; Petrica L; Zamfir AD
    Biomark Med; 2020 Nov; 14(16):1521-1536. PubMed ID: 33090017
    [No Abstract]   [Full Text] [Related]  

  • 77. Relation of homocysteine to early nephropathy in patients with Type 2 diabetes.
    Li J; Shi M; Zhang H; Yan L; Xie M; Zhuang L; Zhu Y; Chen J
    Clin Nephrol; 2012 Apr; 77(4):305-10. PubMed ID: 22445474
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Decreased plasma α-Klotho predict progression of nephropathy with type 2 diabetic patients.
    Kim SS; Song SH; Kim IJ; Lee EY; Lee SM; Chung CH; Kwak IS; Lee EK; Kim YK
    J Diabetes Complications; 2016 Jul; 30(5):887-92. PubMed ID: 27037042
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical significance of urinary liver-type fatty acid-binding protein in diabetic nephropathy of type 2 diabetic patients.
    Kamijo-Ikemori A; Sugaya T; Yasuda T; Kawata T; Ota A; Tatsunami S; Kaise R; Ishimitsu T; Tanaka Y; Kimura K
    Diabetes Care; 2011 Mar; 34(3):691-6. PubMed ID: 21273494
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Urine haptoglobin levels predict early renal functional decline in patients with type 2 diabetes.
    Bhensdadia NM; Hunt KJ; Lopes-Virella MF; Michael Tucker J; Mataria MR; Alge JL; Neely BA; Janech MG; Arthur JM;
    Kidney Int; 2013 Jun; 83(6):1136-43. PubMed ID: 23536133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.